Talk:Shunthi: Difference between revisions

Line 11:

|data4 = Available

|label5 = Contributors

|data5 = --

|data5 = Dravyaguna Team

|label6 = Year of publication

|data6 = ~~2024~~

|data6 = 2026

|label7 = Publisher

|data7 = [[Charak Samhita Research, Training and Skill Development Centre]]

Line 24:

Ginger

==Therapeutic ~~Use1~~==

== Botanical Identity ==

'''Shunthi''', the dried rhizome of ''Zingiber officinale'' Roscoe (Family: '''Zingiberaceae'''), stands as a cornerstone phytopharmaceutical in traditional systems of medicine—particularly Ayurveda—while simultaneously maintaining a robust profile in modern evidence-based pharmacology. Locally referred to as ''Sonth'' or dry ginger, its processing from fresh ginger (''Ardraka'') chemically transforms its active volatile and non-volatile profiles, resulting in a distinct therapeutic matrix that exhibits high bioavailability and pronounced efficacy across multiple physiological systems.

* '''Botanical Name:''' ''Zingiber officinale'' Roscoe

* '''Family:''' Zingiberaceae

* '''Part Used:''' Dried Rhizome

* '''Vernacular Names:''' Shunthi (Sanskrit), Sonth (Hindi), Dry Ginger (English), Shukku (Tamil)

== Ayurvedic Pharmacodynamics (Dravyaguna Profile) ==

In classical Ayurvedic pharmacology, the dehydration of ginger alters its fundamental properties. Unlike fresh ginger, which carries a sharp, drying post-digestive profile, Shunthi undergoes a metabolic transformation that yields a sweet post-digestive effect (''Madhura Vipaka''), rendering it far more tolerable for long-term therapeutic application without aggravating ''Pitta dosha'' excessively.

==Therapeutic Use==

Agnimandya, Bronchial asthma (swasa), Abdominal distension (adhmana), Rheumatoid arthritis (amavata), Anaemia (pandu), Abdominal disorders (udararoga)

==Varieties==

==Bhavaprakash Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, p.13.</ref>==

# Raktabha

# Shweta

== Synonyms in Charak Samhita==

~~== Synonyms in Charak Samhita==~~

Shunthi, Nagara, Shrungavera, Vishwa-bheshajam, Mahaushadha, Ardraka, Vishwa.

==Synonyms in Bhavaprakasha Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, verse no. 44, p.13.</ref>==

Shunthi, Vishva, Vishv, Nagar, Vishvabheshaja, Ushana, Katubhadra, Shringavera, Mahoshadha,

Line 44:

Line 60:

|+ Properties

|-

! Sr.no. !! Pharmacological criteria !! Properties

! Sr.no. !! Pharmacological criteria !! Properties !! Clinical Significance

|-

| 1 || Taste ([[rasa]]) || Pungent (katu)

| 1 || Taste ([[rasa]]) || Pungent (katu) || Stimulates gustatory receptors, secretes salivary and gastric enzymes.

|-

| 2 || Potency ([[veerya]]) ||Hot (ushna)

| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])

|-

| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura)

| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura) || Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.

|-

| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna)

| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna) || Counteracts the coldness of ''Kapha''.

|-

| 5 || Actions ([[karma]]) || Pacify Vata and Kapha

|-

| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.

|}

Line 66:

Line 83:

|-

| 1 ||Cha.Sa.[[Sutra Sthana]] 2/5

| ~~Sirovirechana~~ (Errhine therapy)

| Shirovirechana (Errhine therapy)

|-

| 2 ||Cha.Sa.[[Sutra Sthana]] 2/18

Line 1,155:

Line 1,172:

==Dose<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==

* Churna – 1 – 2 gm

==Important formulations<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==

* Saubhagya Shunthi

* Saubhagya Vati

Line 1,163:

Line 1,182:

* Vaishvanara Churna

== Current availability==

Line 1,175:

Line 1,191:

== Current researches ==

== Phytochemical Architecture ==

The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils:

* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.

* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.

* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.

* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.

== Modern Pharmacological Validation & Therapeutic Efficacy ==

=== A. Gastrointestinal Efficacy (Deepana, Pachana, & Anulomana) ===

Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.

* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT3 receptors''' and cholinergic M3 receptors in the gastrointestinal tract.

* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.

=== B. Anti-Inflammatory & Analgesic Efficacy (Amavataghni) ===

In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.

: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE2) and leukotrienes.

Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.

=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===

Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems:

* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca2+) channel-blocking activity, shifting Ca2+ dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.

* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.

* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.

<pre>

[6]-Shogaol / [6]-Gingerol (Active Constituents)

│

┌────────────────┴────────────────┐

▼ ▼

Inhibition of NF-κB Ca²⁺ Channel Blockade

│ │

▼ ▼

↓ COX-2 & LOX Pathways Vasodilation of

(↓ CRP, ↓ TNF-α, ↓ PGE₂) Vascular Smooth Muscle

│ │

▼ ▼

Clinical: Alleviation of Clinical: Reduction of

Arthritis & Joint Pain Systemic Blood Pressure

</pre>

== Clinical Safety, Dosage, and Contraindications ==

Shunthi enjoys a wide therapeutic index and is designated as '''GRAS''' (Generally Recognized as Safe) by global regulatory bodies. However, its high thermal potency warrants structured clinical application.

* '''Standard Therapeutic Dosage:'''

** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.

** ''Extract:'' 250 - 500 mg two to three times daily.

* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.

* '''Drug Interactions:''' Due to its mild anti-platelet and calcium-channel-blocking properties, cautious monitoring is recommended when co-administered with high-dose synthetic anticoagulants (e.g., Warfarin) or prescription antihypertensives.

* '''Contraindications:''' Acute peptic ulceration, active GI bleeding, and inflammatory dermatological conditions characterized by extreme ''Pitta'' vitiation.

== References ==

# '''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.

# '''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.

# '''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.

# '''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.

# '''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.

# '''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.

[[Category: Database of herbs and minerals | Herbs]]

~~This article is under development ..~~

@@ Line 11: / Line 11: @@
 |data4 = Available
 |label5 = Contributors
-|data5 = --
+|data5 = Dravyaguna Team
 |label6 = Year of publication
-|data6 =  2024
+|data6 =  2026
 |label7 = Publisher
 |data7 =  [[Charak Samhita Research, Training and Skill Development Centre]]
@@ Line 24: / Line 24: @@
 Ginger
-==Therapeutic Use1==
+== Botanical Identity ==
+'''Shunthi''', the dried rhizome of ''Zingiber officinale'' Roscoe (Family: '''Zingiberaceae'''), stands as a cornerstone phytopharmaceutical in traditional systems of medicine—particularly Ayurveda—while simultaneously maintaining a robust profile in modern evidence-based pharmacology. Locally referred to as ''Sonth'' or dry ginger, its processing from fresh ginger (''Ardraka'') chemically transforms its active volatile and non-volatile profiles, resulting in a distinct therapeutic matrix that exhibits high bioavailability and pronounced efficacy across multiple physiological systems.
+* '''Botanical Name:''' ''Zingiber officinale'' Roscoe
+* '''Family:''' Zingiberaceae
+* '''Part Used:''' Dried Rhizome
+* '''Vernacular Names:''' Shunthi (Sanskrit), Sonth (Hindi), Dry Ginger (English), Shukku (Tamil)
+== Ayurvedic Pharmacodynamics (Dravyaguna Profile) ==
+In classical Ayurvedic pharmacology, the dehydration of ginger alters its fundamental properties. Unlike fresh ginger, which carries a sharp, drying post-digestive profile, Shunthi undergoes a metabolic transformation that yields a sweet post-digestive effect (''Madhura Vipaka''), rendering it far more tolerable for long-term therapeutic application without aggravating ''Pitta dosha'' excessively.
+==Therapeutic Use==
 Agnimandya, Bronchial asthma (swasa), Abdominal distension (adhmana), Rheumatoid arthritis (amavata), Anaemia (pandu), Abdominal disorders (udararoga)
 ==Varieties==
 ==Bhavaprakash Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, p.13.</ref>==
 # Raktabha
 # Shweta
+== Synonyms in Charak Samhita==
-== Synonyms in Charak Samhita==
 Shunthi, Nagara, Shrungavera, Vishwa-bheshajam, Mahaushadha, Ardraka, Vishwa.
 ==Synonyms in Bhavaprakasha Nighantu<ref>Prof. K.C.Chunekar, Bhavprakasha Nighantu, Reprint.2015, Chaukhambha vishvabharti, Haritakyadi Varga, verse no. 44, p.13.</ref>==
 Shunthi, Vishva, Vishv, Nagar, Vishvabheshaja, Ushana, Katubhadra, Shringavera, Mahoshadha,
@@ Line 44: / Line 60: @@
 |+ Properties
 |-
-! Sr.no. !! Pharmacological criteria !! Properties
+! Sr.no. !! Pharmacological criteria !! Properties !! Clinical Significance
 |-
-| 1 || Taste ([[rasa]])  || Pungent (katu)
+| 1 || Taste ([[rasa]])  || Pungent (katu) || Stimulates gustatory receptors, secretes salivary and gastric enzymes.
 |-
-| 2 || Potency ([[veerya]]) ||Hot (ushna)
+| 2 || Potency ([[veerya]]) ||Hot (ushna) || Enhances metabolic rate (''Agni'') and clears systemic micro-channels ([[Srotas]])
 |-
-| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura)
+| 3 || Post digestion effect ([[vipaka]]) || Sweet (madhura) || Imparts nourishing, tissue-protective, and rejuvenative (''Rasayana'') long-term effects.
 |-
-| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna)
+| 4 || Qualities ([[guna]])|| Heavy (guru), Rough (ruksha), Sharp (tikshna) || Counteracts the coldness of ''Kapha''.
 |-
 | 5 || Actions ([[karma]]) || Pacify Vata and Kapha
 |-
+| 6 || [[Prabhava]] (Special Action) || Amavataghni / Grahi || Specifically targets rheumatoid conditions; acts as a bowel-binding bio-absorbent.
 |}
@@ Line 66: / Line 83: @@
 |-
 | 1 ||Cha.Sa.[[Sutra Sthana]] 2/5
-| Sirovirechana (Errhine  therapy)
+| Shirovirechana (Errhine  therapy)
 |-
 | 2 ||Cha.Sa.[[Sutra Sthana]] 2/18
@@ Line 1,155: / Line 1,172: @@
 ==Dose<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==
 * Churna – 1 – 2 gm
 ==Important formulations<ref>Anonymous. The Ayurvedic Pharmacopoeia of India. Department of Ayush, Ministry of Health and Family welfare, Govt. of India, New Delhi, Part I. 1986; Volume I:65.</ref>==
 * Saubhagya Shunthi
 * Saubhagya Vati
@@ Line 1,163: / Line 1,182: @@
 * Vaishvanara Churna
 == Current availability==
@@ Line 1,175: / Line 1,191: @@
 == Current researches ==
+== Phytochemical Architecture ==
+The processing of fresh ginger into Shunthi significantly shifts its chemical composition. The primary thermogenic and bioactive markers are phenolic compounds and volatile oils:
+* '''Gingerols ([6]-, [8]-, and [10]-gingerol):''' The primary pungent fluid components dominant in fresh ginger.
+* '''Shogaols ([6]-, [8]-, and [10]-shogaol):''' Formed via the thermal dehydration of gingerols during the drying process. '''[6]-shogaol''' exhibits up to twice the anti-inflammatory and antioxidant potency of its precursor, making Shunthi pharmacologically distinct from fresh ginger.
+* '''Zingerone & Paradols:''' Secondary degradation products that contribute significantly to free-radical scavenging.
+* '''Volatile Oils (Sesquiterpenes):''' Comprising α-zingiberene, β-sesquiphellandrene, and ar-curcumene, responsible for its distinct aromatic properties.
+== Modern Pharmacological Validation & Therapeutic Efficacy ==
+=== A. Gastrointestinal Efficacy (Deepana, Pachana, & Anulomana) ===
+Shunthi acts as a potent prokinetic and antiemetic agent via central and peripheral mechanisms.
+* '''Antiemetic & Nausea Regulation:''' Clinical meta-analyses validate that oral doses ranging from 500 mg to 1,500 mg daily significantly reduce pregnancy-associated nausea and vomiting (NVP) as well as chemotherapy-induced emesis. The mechanism is mediated via the competitive antagonism of peripheral '''5-HT<sub>3</sub> receptors''' and cholinergic M3 receptors in the gastrointestinal tract.
+* '''Gastroprotective and Prokinetic Action:''' Shunthi accelerates gastric emptying and stimulates gastric acid, bile, and pancreatic enzyme secretion, effectively resolving functional dyspepsia, abdominal bloating, and colicky pain.
+=== B. Anti-Inflammatory & Analgesic Efficacy (Amavataghni) ===
+In conditions like Rheumatoid Arthritis (''Amavata'') and Osteoarthritis, Shunthi acts as a natural dual-inhibitor of inflammatory cascades.
+: '''Biochemical Mechanism:''' The active fractions ([6]-shogaol and [6]-gingerol) suppress the activation of Nuclear Factor-kappa B ('''NF-κB'''). This leads to down-regulation of '''COX-2''' (Cyclooxygenase-2) and '''LOX''' (Lipoxygenase) pathways, preventing the synthesis of pro-inflammatory prostaglandins (PGE<sub>2</sub>) and leukotrienes.
+Unlike conventional Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Shunthi exerts these anti-inflammatory and antinociceptive actions without compromising the gastric mucosa, due to its concurrent cytoprotective mucin-stimulating properties.
+=== C. Cardio-Metabolic and Vascular Regulation (Hrudya) ===
+Recent clinical and animal trials demonstrate that Shunthi exerts a multi-target protective effect on the cardiovascular and metabolic systems:
+* '''Calcium Channel Blockade:''' Shunthi extracts display calcium (Ca<sup>2+</sup>) channel-blocking activity, shifting Ca<sup>2+</sup> dose-response curves to relax vascular smooth muscles. This results in vasodilation and a systemic reduction in blood pressure.
+* '''PPARα Agonism:''' It activates Peroxisome Proliferator-Activated Receptor alpha (PPARα), enhancing fatty acid oxidation in myocytes, thereby attenuating myocardial hypertrophy and reducing risks of atherosclerosis.
+* '''Glycemic Control:''' Meta-analyses show that daily supplementation significantly lowers '''HbA1c''' and fasting blood glucose in Type 2 Diabetes Mellitus patients by improving insulin sensitivity and up-regulating GLUT4 transporters.
+<pre>
+       [6]-Shogaol / [6]-Gingerol (Active Constituents)
+                         │
+        ┌────────────────┴────────────────┐
+        ▼                                 ▼
+Inhibition of NF-κB               Ca²⁺ Channel Blockade
+        │                                 │
+        ▼                                 ▼
+ ↓ COX-2 & LOX Pathways             Vasodilation of
+(↓ CRP, ↓ TNF-α, ↓ PGE₂)         Vascular Smooth Muscle
+        │                                 │
+        ▼                                 ▼
+Clinical: Alleviation of           Clinical: Reduction of
+ Arthritis & Joint Pain            Systemic Blood Pressure
+</pre>
+== Clinical Safety, Dosage, and Contraindications ==
+Shunthi enjoys a wide therapeutic index and is designated as '''GRAS''' (Generally Recognized as Safe) by global regulatory bodies. However, its high thermal potency warrants structured clinical application.
+* '''Standard Therapeutic Dosage:'''
+** ''Churna (Crude Powder):'' 1 - 3 g per day in divided doses.
+** ''Extract:'' 250 - 500 mg two to three times daily.
+* '''Adverse Effects:''' Excessive consumption on an empty stomach may occasionally cause mild heartburn, eructation, or gastric irritation in highly sensitive ''Pitta''-dominant individuals.
+* '''Drug Interactions:''' Due to its mild anti-platelet and calcium-channel-blocking properties, cautious monitoring is recommended when co-administered with high-dose synthetic anticoagulants (e.g., Warfarin) or prescription antihypertensives.
+* '''Contraindications:''' Acute peptic ulceration, active GI bleeding, and inflammatory dermatological conditions characterized by extreme ''Pitta'' vitiation.
+== References ==
+# '''Unuofin, J. O., et al.''' (2021). ''Phytochemical structures and therapeutic potentials of Zingiber officinale compounds.'' Journal of Ethnopharmacology, 273, 113997.
+# '''Jalali, M., et al.''' (2020). ''The effects of ginger supplementation on biomarkers of oxidative stress: A systematic review and meta-analysis of randomized controlled trials.'' Clinical Nutrition, 39(12), 3598-3606.
+# '''Ayurvedic Pharmacopoeia of India (API).''' ''Zingiber officinale Rosc. - Rhizome Monograph.'' Part-I, Volume I, Government of India, Ministry of Health and Family Welfare.
+# '''Wang, J., et al.''' (2017). ''Beneficial effects of ginger on Type 2 Diabetes Mellitus and Metabolic Syndrome: A systems-level overview.'' Phytomedicine, 34, 184-198.
+# '''Ernst, E., & Pittler, M. H.''' (2000). ''Efficacy of ginger for nausea and vomiting: A systematic review of randomized clinical trials.'' British Journal of Anaesthesia, 84(3), 367-371.
+# '''Schepici, G., et al.''' (2021). ''The anti-inflammatory potential of ginger and its constituents in neurodegenerative and arthritic diseases.'' Molecules, 26(18), 5642.
 [[Category: Database of herbs and minerals | Herbs]]
- This article is under development ..